Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 568,168 | 296,492 | 638,400 | 276,443 | 209,447 |
Marketable Securities | 282,585 | 314,906 | 289,053 | 875,438 | 848,495 |
Receivables | 280,512 | 261,535 | 254,014 | 275,014 | 278,637 |
Inventories | 182,815 | 227,469 | 243,538 | 236,624 | 251,016 |
Income taxes - deferred | N/A | 149,187 | 145,006 | 90,568 | 86,880 |
Other current assets | 318,771 | 285,623 | 226,291 | 229,640 | 256,569 |
TOTAL | $1,632,851 | $1,535,212 | $1,796,302 | $1,983,727 | $1,931,044 |
Non-Current Assets | |||||
PPE Net | 1,174,396 | 1,093,680 | 1,150,420 | 1,561,918 | 1,525,225 |
Investments And Advances | 1,468,439 | 1,477,403 | 1,031,010 | 1,149,172 | 1,265,557 |
Intangibles | 4,106,031 | 4,208,314 | 4,290,420 | 4,367,877 | 4,443,932 |
TOTAL | $6,748,866 | $6,779,397 | $6,471,850 | $7,078,967 | $7,234,714 |
Total Assets | $8,381,717 | $8,314,609 | $8,268,152 | $9,062,694 | $9,165,758 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 99,780 | 48,210 | 66,004 | 75,015 | 121,471 |
Accrued Expenses | 297,833 | 241,781 | 235,457 | 219,142 | 247,802 |
TOTAL | $597,806 | $558,945 | $540,653 | $1,228,529 | $1,260,748 |
Non-Current Liabilities | |||||
Long Term Debt | 43,444 | 42,925 | 42,405 | 94,757 | 101,879 |
Deferred Revenues | N/A | 18,603 | 16,389 | 20,778 | 13,695 |
aiOther Non-Current Liabilities | 72,309 | 58,615 | 57,259 | 62,598 | 54,959 |
TOTAL | $878,035 | $957,837 | $981,685 | $1,053,206 | $1,078,609 |
Total Liabilities | $1,475,841 | $1,516,782 | $1,522,338 | $2,281,735 | $2,339,357 |
Shareholders' Equity | |||||
Shares Outstanding, K | 344,099 | 339,410 | 338,337 | 344,628 | 344,027 |
Common Shares | 173 | 175 | 175 | 173 | 173 |
Retained earnings | -1,021,644 | -802,311 | -793,384 | -808,423 | -801,094 |
Other shareholders' equity | -56,564 | -59,780 | -74,525 | -91,224 | -42,657 |
TOTAL | $6,905,876 | $6,797,827 | $6,745,814 | $6,780,959 | $6,826,401 |
Total Liabilities And Equity | $8,381,717 | $8,314,609 | $8,268,152 | $9,062,694 | $9,165,758 |